Current Issue 2018  Archive 2017 
Biography
Biography

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

Biography

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.

Special Issue

Current State of Evaluation and Management of Infectious Conditions in Liver Transplant Candidates and Recipients

Submission Deadline: July 30, 2018 (Open)               Submit Now

Guest Editor

Wasim A. Dar, MD, PhD
Assistant Professor of Surgery, Division of Immunology and Organ Transplantation, Department of Surgery, University of Texas at Houston, Health Sciences Center, 6431 Fannin, MSB 6.240, Houston, TX 77030, USA
Tel.: (713) 500-7401 (O); (713) 500-0875 (F)
E-Mail: [email protected]
Website: http://www.uth.tmc.edu/schools/med/surgery/organ_transplant/faculty/bio-Dar-Wasim.html
Research Interests: liver transplantation; kidney transplantation; pancreas transplantation; laparoscopic donor nephrectomy; dialysis access surgery; hepatobiliary surgery; general surgery

About This Topic

Liver transplantation is a critical therapy for the effective management of patients suffering from the complications of end stage liver disease. Outcomes from liver transplantation are vastly improved from the days of its early practice due to increasing technical proficiency during the surgery itself. However this has brought to light other important factors that influence survival including the morbidity and mortality from pre- and post-transplant infectious conditions. Evaluation and management of these infectious conditions therefore will continue to play a larger role in both selecting appropriate transplant candidates and management of patients after receiving a liver transplant. In this special issue of OBM Transplantation we are soliciting scholarly articles devoted to reviewing the current paradigms of care related to such topics as HIV and liver transplantation, the management of Hepatitis B and C pre- and post-transplant, viral reactivation diseases after liver transplantation, and fungal and bacterial diseases and their management affecting liver transplant recipients.

Planned Papers

Title: HIV in Liver Transplantation
Author: Marshall Lyon

Title: Viral Reactivation Diseases in Liver Transplantation
Author: Aneesh Mehta

Title: Bacterial Infections in Liver Transplantation
Author: Masayuki Nigo

Title: Invasive Fungal Infections in Liver Transplant Recipients
Author: Anita Verma, King's College Hospital, Institute of Liver Studies, London, UK

Publication

Editorial

Infectious Complications in Liver Transplantation

Wasim A. Dar
Received: September 03, 2018; Published: September 29, 2018; ; doi:10.21926/obm.transplant.1803021

Review

Evolution in the Management of Invasive Fungal Infections in Liver Transplant Recipients

Anita Verma, Katharina Sophia Weigel, Sim You Kuan Dexter, Anil Dhawan
Received: March 26, 2018; Published: May 30, 2018; ; doi:10.21926/obm.transplant.1802009